Expression of CD44 variants in lung cancer and its relationship to hyaluronan binding

Journal of International Medical Research

Volumn 28, Issue 2, 2000, Pages 78-90

  Matsubara, Y ^a   Katoh, S ^b   Taniguchi, H ^a   Oka, M ^a   Kadota, J ^a   Kohno, S ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

CD44; Hyaluronan; Lung cancer

Indexed keywords

CD44V ANTIGEN; HYALURONIC ACID; SIALIDASE;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DEGLYCOSYLATION; HUMAN; HUMAN CELL; LUNG CANCER;

EID: 0034130931     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000002800203     Document Type: Article

References (25)

1. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I: Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 1994; 180: 53-66.
2. Picker LJ, De los Toyos J, Telen MJ, et al: Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J Immunol 1989; 142: 2046-2051.
3. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with the extracellular matrix. Adv Immunol 1993; 54: 271-335.
4. DeGrendele HC, Kosfiszer M, Estess P, et al: CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 1997; 159: 2549-2553.
5. Hathcock KS, Hirano H, Murakami S, et al: CD44 expression on activated B cells. Differential capacity for CD-44 dependent binding to hyaluronic acid. J Immunol 1993; 151: 6712-6722.
6. Moll J, Schmidt A, van der Putten H, et al: Accelerated immune response in transgenic mice expressing rat CD44v4-v7 on T Cells. J Immunol 1996; 156: 2085-2094.
7. Screaton GR, Bell MV, Jackson DG, et al: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160-12164.
8. Takeuchi K, Yamaguchi A, Urano T, et al: Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis. Jpn J Cancer Res 1995; 86: 292-297.
9. Yamaguchi A, Saito M, Goi T, et al: Expression of CD44 variant exons 8-10 in gastric cancer. Jpn J Cancer Res 1995; 86: 1166-1171.
10. Tokue Y, Matsumura Y, Katsumata N, et al: CD44 variant isoform expression and breast cancer prognosis. Jpn J Cancer Res 1998; 89: 283-290.
11. Cannistra SA, DeFranzo B, Niloff J, et al: Functional heterogeneity of CD44 molecules in ovarian cancer cell lines. Clin Cancer Res 1995; 1: 333-342.
12. Takigawa N, Segawa Y, Mandai K, et al: Serum CD44 levels in patients with non-small cell lung cancer and their relationship with clinicopathological features. Lung Cancer 1997; 18: 147-157.
13. Washimi O, Ueda R, Ariyoshi Y, et al: Expression of CD44 variant isoforms in normal and neoplastic cells of the lung. Jpn J Cancer Res 1994; 85: 1112-1116.
14. Wimmel A, Schilli M, Kaiser U, et al: Preferential histiotypic expression of CD44 isoforms in human lung cancer. Lung Cancer 1997; 16: 151-172.
15. Bennett KL, Modrell B, Greenfield B, et al: Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol 1995; 131: 1623-1633.
16. Katoh S, Zheng Z, Oritani K, et al: Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 1995; 182: 419-429.
17. Saegusa M, Okayasu I: Up-regulation of CD44 variant exon expression in endometrial carcinomas: analysis of mRNA and protein isoforms, and relation to clinicopathological factors. Jpn J Cancer Res 1998; 89: 291-298.
18. Jun Z, Hill PA, Lan HY, et al: CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis. Clin Exp Immunol 1997; 108: 69-77.
19. Liao HX, Lee DM, Levesque MC, et al: N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. J Immunol 1995; 155: 3938-3945.
20. Perschl A, Lesley J, English N, et al: Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol 1995; 25: 495-501.
21. Pure E, Camp RL, Peritt D, et al: Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J Exp Med 1995; 181: 55-62.
22. Takahashi K, Stamenkovic I, Cutler M, et al: Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J Biol Chem 1996; 271: 9490-9496.
23. Lesley J, English N, Perschl A, et al: Variant cell lines selected for alterations in the function of the hyaluronan recepter CD44 show differences in glycosylation. J Exp Med 1995; 182: 431-437.
24. Timothy PS, Zeng C, Nocks A, et al: Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol 1998; 140: 431-446.
25. Zheng Z, Cummings RD, Pummill PE, et al: Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by chinese hamster ovary cells. J Clin Invest 1997; 100: 1217-1229.